Smart Money Circle

This Biotech CEO Is Architecting Bioregeneration – Meet Miles Harrison President and CEO - Conexu Sciences $CNXU

Guest:

Miles Harrison President and CEO - Conexu Sciences $CNXU

Bio:

Miles Harrison President and CEO, Director Miles Harrison is a healthcare and aesthetics executive with a proven record of scaling global businesses, driving innovation, and creating shareholder value.

He currently serves on the Board of Castle Biosciences (NASDAQ: CSTL), and sits on the Compensation Committee and Nominating and Governance Committee, Castle Biosciences provides test solutions for the diagnosis and treatment of dermatologic cancers.

Previously, Miles co-founded and led Novaestiq Corp., building a novel aesthetics platform, raising multi-millions in early financing, and securing strategic distribution with Croma Pharma in North America. He successfully positioned Novaestiq for a significant strategic exit in 2025. Before Novaestiq, Miles was President & General Manager, North America at Galderma, leading three business units—Aesthetics, Consumer, and Prescription—across North America, with an expansive employee base and over $1.2B in revenue.

He drove sustained growth and margin expansion, and scaled several iconic consumer, aesthetic and prescription brands including Cetaphil®, Differin®, Dysport®, Sculptra®, Restylane® and Epiduo®. Miles was part of the executive leadership team that supported EQT’s multi billion dollar acquisition of Galderma in late 2019. Earlier, at Nestlé Skin Health, he built the U.S. Consumer Business Unit from the ground up, delivering double-digit organic growth and leading the first FDA-approved RX-to-OTC acne switch in 30 years (Differin® Gel).

Miles seeks to bring a blend of boardroom discipline and entrepreneurial drive to his next role as CEO of Conexeu™ Sciences Inc. Known for building high-performing teams and shaping cultures that thrive under change, he combines governance depth, capital strategy expertise, and hands-on operating leadership. At Conexeu™, he will lead the charge to bring first-in-class disruptive human collagen technologies to market across aesthetics, wound care, and regenerative medicine—pioneering a category that sits at the intersection of science, patient impact, and long-term value creation.

Conexecu Sciences Inc. Nasdaq: CNXU

https://www.conexeu.com/

About Conexeu Sciences Inc. Architecting BioregenerationTM.

Conexeu Sciences is a preclinical-stage regenerative tissue platform company. Our patented extracellular matrix (ECM) platform, CXU™, is built on a single structural principle and is designed to support bioregeneration: one formula, one device, designed to scale across multiple addressable markets. Conexeu is targeting large, multi-billion-dollar end markets, including wound care, periodontal applications, and facial and body tissue restoration, including the tissue changes that can follow GLP-1 weight loss, with further expansion opportunities in 3D printing and biofabrication workflows and the veterinary market. The Company is advancing a predicate-based U.S. regulatory strategy with an anticipated 510(k) submission in early 2027 for its initial indication, subject to regulatory review. Conexeu is led by an experienced leadership team with deep expertise in biomaterials, regenerative medicine, and medical device commercialization and development.

Timeless Advice From The Chief Investment Officer Of A $10 Billion Firm

Meet

Stuart Katz, Chief Investment Officer, Robertson Stephens

(AUM: $9.5B)

Bio

Stuart Katz creates and leads the firm’s investment strategy, global asset allocation, portfolio analytics, risk management, manager selection and overall long-term strategic portfolio and near-term tactical asset allocation investment process.

Stuart has more than 30 years of institutional and family office investment experience as both a direct investor and allocator across traditional public asset classes and alternative strategies.

He began his career at Goldman, Sachs & Co., where he worked for 15 years in New York and London, serving in multiple roles including overseeing private equity and private credit investments in the Merchant Banking Division across financial services, media, industrial and other sectors. Stuart has served on several public and private company boards.

Working extensively with ultra high net worth investors and advisors over the years, Stuart has learned that first understanding a client’s goals and values is critical to building a strong investment portfolio. It is a philosophy he embraces at Robertson Stephens as part of a fiduciary mindset defined by transparency, unbiased advice, and the freedom to pursue the best investment option for every client. His insights have been featured across media such as CNBC.com, Reuters, Business Insider, the Wall Street Journal, InvestmentNews, CIO Magazine, Barron’s and Bloomberg Asia.

Prior to joining Robertson Stephens, Stuart also served as:

* President and Founding Member responsible for establishment of The Heyman Enterprise LLC, a single family investment office

* Managing Director and member of the Investment Committee of alternative asset management firm, Amber Capital LP

Stuart, who serves as Chair of the Investment Committee for Robertson Stephens, earned an MBA from Harvard Graduate School of Business and an AB from Dartmouth College where he graduated Phi Beta Kappa, magna cum laude. He also studied at the London School of Economics.

He lives with his wife in New York City and enjoys cheering for his daughters in track, cross country and ultimate frisbee events.

Guest

Isaac Wakszol is the CEO of Activest Wealth Management

Company

Activest Wealth Management

Website

https://activestwm.com/

Assets

3B AUA

1.7B AUM

Isaac’s Bio

Before founding Activest, he represented a Swiss private investment bank in Venezuela, gaining valuable international finance insights.

His academic credentials include a civil engineering degree from Universidad Metropolitana and an MBA from IESA Venezuela and Babson College. Fluent in English and Spanish, he holds a Series 65 license, reflecting his deep commitment to financial services.

As Founder and CEO of Activest Wealth Management, he leads with a focus on strategic initiatives, investment management, and enhancing client relationships. His extensive experience in the financial sector began in 1996, shaping his skills in portfolio management and financial planning, both domestically and internationally.

Outside of his professional endeavors, he is an avid runner and an active member of the Jewish community in Aventura, Florida, where he has been residing since 2008. His commitment extends beyond business to include significant community and family engagements, making him a well-rounded leader and influencer in both his professional and personal life.

Company Bio:

We provide personalized financial advisory services through a skilled, passionate team dedicated to transforming your financial experience from a human perspective.

This CEO Is Using Lidar To help Autonomous Driving- Meet Matt Fisch CEO AEYE $LIDR

Matt Fisch

Chairman & Chief Executive Officer, AEye, Inc. $LIDR

Matt Fisch is Chief Executive Officer of AEye, Inc. (NASDAQ: LIDR), a global leader in adaptive, high-performance lidar solutions for automotive, trucking, intelligent transportation systems, and smart infrastructure applications. He brings decades of executive leadership experience across the automotive technology, mobility, and industrial sectors, with a strong track record of scaling technology businesses, driving commercial growth, and leading strategic transformations. As CEO, Matt is focused on accelerating AEye's commercialization strategy, expanding strategic partnerships, and delivering next-generation sensing solutions that enable safer, smarter, and more autonomous transportation.

Company:

AEye, Inc. (NASDAQ: LIDR)

https://www.aeye.ai

Bio

AEye is a global leader in adaptive, high-performance lidar technology designed to help vehicles and infrastructure perceive the world with greater precision, range, and intelligence. Its software-defined lidar platform delivers long-range detection, rapid response times, and dynamic adaptability for automotive, commercial trucking, intelligent transportation systems, and smart infrastructure applications. By combining advanced sensing with AI-driven perception, AEye enables safer mobility, supports autonomous driving innovation, and enhances traffic management and road safety worldwide.

To learn more, visit https://www.aeye.ai

VC Investments In A Publicly Traded Fund - Meet Dr. Naj – CEO C1 Fund - $CFND

Guest

Dr. Najamul Kidwai, Co-Founder, President, and Chief Executive Officer

C1fund --CFND

Najam Kidwai -

Company

C1 Fund (NYSE: CFND)

www.c1fund.com

Guest Bio

Dr. Kidwai is a seasoned entrepreneur, investor, and operator with a deep passion for innovation and emerging technologies. As a co-founder, he has served as President, CEO, and Director of the company since its inception, helping shape its strategic vision from the ground up.

He brings a rich track record of building and backing transformative ventures. From 2021 to 2022, Dr. Kidwai served as Chairman and Director of Crypto 1 Acquisition Corp, a SPAC focused on digital assets, blockchain, and crypto infrastructure, where he led a successful $230 million raise. He is also a Venture Partner and Investment Committee Member at Frontier Ventures, an early-stage venture fund investing in next-gen tech and blockchain startups.

Since 2017, Dr. Kidwai has been a co-founder and Executive Committee member of EQUIAM, a leading venture capital fund focused on private markets. Through EQUIAM and other platforms, he has invested in a wide range of pioneering companies, including TransFi, Klickl, Forge Global, and Destiny XYZ, among others. He continues to actively back and advise startups operating at the intersection of technology and finance.

An early believer in digital assets, Dr. Kidwai has been investing in crypto and blockchain since 2016. His operating experience includes founding Real Time Content, a dynamic media personalization platform that was acquired by NASDAQ-listed Pitney Bowes.

Earlier in his career, he held investment roles at Edge Venture Capital and AtomicTangerine, a venture consultancy spun out of SRI International.

Dr. Kidwai holds a B.Sc. (Hons) in Technology Management from Staffordshire University and honorary doctorates from both Lincoln University and Staffordshire University.

Company Bio

C1 Fund (NYSE: CFND)

C1 Fund Inc. is a closed-end investment fund designed to give investors access to the private digital asset ecosystem. Managed by C1 Advisors, the fund targets a handpicked portfolio of the leading, late-stage private companies driving the future of digital asset services and technology.

C1 Fund is built for investors seeking more than market exposure — it offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the leading private companies with the safeguards of a NYSE listed fund that is regulated and liquid. With a disciplined focus on innovation, scale, and institutional-grade governance, C1 Fund positions investors at the forefront of digital asset evolution.

For more information about C1 Fund, please visit the Company’s website at www.c1fund.com.

Guest

Andrew Paradise - Founder & CEO – FIRY

Company

FIRY Inc. (NYSE:FIRY)

Website: http://www.firy.com

Andrew's Bio

Andrew Paradise, FIRY’s Chief Executive Officer and Founder, is the inventor of real-money skill-based gaming and founded Skillz in 2012. Under his leadership, Skillz became the first publicly traded mobile esports platform and a global leader in mobile gaming, hosting billions of tournaments and distributing millions of dollars in prizes each month. Paradise holds more than 90 issued patents spanning matchmaking algorithms, fraud detection, real-time competition systems, and skill-based gaming infrastructure.

Under Paradise’s leadership, FIRY is focuses on advancing its technology platforms and expanding opportunities across competitive gaming, AI-powered advertising, and game-development infrastructure. In 2026, the company also advanced its platform strategy through the integration of Beamable technology, designed to provide developers with enhanced backend, live-operations, and monetization capabilities.

To learn more, visit FIRY Inchttp://www.firy.com.

Company Bio

FIRY Inc. (NYSE:FIRY) is a technology company focused on building platforms that power the future of competitive gaming, advertising technology, and game development. Formerly known as Skillz Inc., the company completed its rebrand to FIRY in 2026 as part of a broader restructuring that brings together three businesses: Skillz, RZR, an AI-powered advertising technology platform, and Beamable, a live-operations and developer platform.

This CEO is Fighting Parkinson’s And Other Neuro-Degenerative Diseases – Meet Gain Therapeutics GANX CEO

Guest:

Gene Mack, CEO, Gain Therapeutics

Guest’s Bio:

Gene Mack serves as Chief Executive Officer and President of Gain Therapeutics. He joined the Company in April 2024 and brings 25 years of experience in the life sciences sector spanning clinical research, financing and capital markets, investing, corporate strategy and business development. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023.

Previous to Imcyse, Gene was CFO at OncoC4, a privately held biotechnology company that spun out of Merck & Co’s (MSD) $475 million acquisition of OncoImmune in 2020 where he had also been CFO. Before that, he has held the CFO role for several development- and commercial-stage biopharmaceutical companies, raising over $350 million in IPO and other equity transactions.

Prior to his operational experience, Gene covered the biotechnology and life sciences sector as a senior publishing analyst at various investment banks, including Gruntal & Co, Lazard, Mizuho, and HSBC. Gene received both his B.S. in Biochemistry and M.B.A. in Finance from Fordham University.

Company:

Gain Therapeutics ($GANX)

Company Description:

Gain Therapeutics, a clinical-stage biotechnology company headquartered in Bethesda focused on developing novel allosteric small molecule therapies for neurodegenerative diseases.

Under Gene’s leadership, the company is advancing its lead candidate, GT-02287, with recent Phase 1b data presented at AD/PD 2026 demonstrating encouraging biomarker improvements, including reductions in DDC and glucosylsphingosine, as well as durable clinical outcomes through 150 days of treatment in Parkinson’s disease.

Underwater Drones? The Future Of Underwater Robotics.Meet John Gibson, CEO, Nauticus Robotics

Guest

John Gibson, President & CEO Nauticus Robotics, Inc.$KITT

Company

Nauticus Robotics, Inc
Websitehttps://nauticusrobotics.com/
Nasdaq: KITT

Company Bio

Guest

Cory S. Krebs, CFA CooksonPeirce

President and Chief Executive Officer

Company

CooksonPeirce

Website

https://cooksonpeirce.com/

AUM

Over $3B AUM

About Cory

Cory S. Krebs, CFA

President and Chief Executive Officer

As president and chief executive officer for CooksonPeirce, Cory Krebs is tasked with defining corporate strategy and executing the firm’s business plan. Cory is also a member of the firm’s portfolio management team, tasked with the administration of all CooksonPeirce investment strategies, including the Catalyst Dynamic Alpha Fund.

Prior to joining CooksonPeirce in 2003, Cory spent five years with Laurel Capital Advisors, an investment subsidiary of Mellon Financial, where he was responsible for all aspects of block order trading, participated in new product development, and assisted in the investment manager due diligence process. Before that, he served in a variety of positions at Federated Investors and American Express Financial Advisors.

Cory earned a B.A. in economics and an M.B.A. from the University of Pittsburgh. He also attained the designation of Chartered Financial Analyst from the CFA Institute. He is a member of the CFA Institute and the CFA Society of Pittsburgh. He is also a member of the Pittsburgh Society of Investment Professionals, where he has served on the board of directors and as president of the organization.

A proud honors graduate, Cory is a lifetime member of the University of Pittsburgh Alumni Association and the Panther Club. He lives in the South Hills with his wife and three school-aged children.

About CooksonPeirce

CooksonPeirce, registered in 1984, serves 47 states with a licensed staff of 10 advisors. Headquartered in Pittsburgh, PA, with satellite offices in Ohio, South Carolina, and Florida, CooksonPeirce manages over $3 billion and provides investment advisory services for more than 1,200 clients.

Important Disclosures

Investing involves risk, including possible loss of principal. Investment decisions are subject to market, currency, economic, and business risks and will not always be profitable. There is no guarantee that risk can be successfully mitigated or otherwise avoided.

Nothing herein is an offer to buy or a suggestion to sell securities. Statements using "if," "may," "can," "should," or "will" may be forward looking and are not intended as an opinion, projection, or estimate regarding the market, CooksonPeirce, or its products.

AUM of $3 billion as of June 30, 2026, subject to change.

CooksonPeirce & Co., Inc. is an SEC registered investment adviser. Registration does not imply a certain level of skill or training. See Form ADV at adviserinfo.sec.gov.